Molecular assays for the detection and characterization of CTCS

Recent Results in Cancer Research

Volumn 195, Issue , 2012, Pages 111-123

  Lianidou, Evi S ^a   Markou, Athina ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MAMMAGLOBIN; MICRORNA; PROGESTERONE RECEPTOR;

ARTICLE; CANCER DIAGNOSIS; CANCER STEM CELL; CELL COUNT; CIRCULATING TUMOR CELL; DNA METHYLATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; INTERMETHOD COMPARISON; LIQUID BEAD ARRAY; MICROARRAY ANALYSIS; MICROMETASTASIS; MOLECULAR DIAGNOSIS; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

GENE EXPRESSION PROFILING; HUMANS; NEOPLASTIC CELLS, CIRCULATING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84860547276     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-28160-0_10     Document Type: Article

References (52)

1. Pantel K, Alix-Panabieres C, Riethdorf S (2009) Cancer micrometastases. Nat Rev Clin Oncol 6:339-351
2. Hayes DF, Smerage JR (2008) Is there a role for circulating tumor cells in the management of breast cancer? Clin Cancer Res 14:3646-3650
3. Kasimir-Bauer S (2009) Circulating tumor cells as markers for cancer risk assessment and treatment monitoring. Mol Diagn Ther 13:209-215
4. Stathopoulou A, Vlachonikolis I, Mavroudis D, Perraki M, Georgoulias V et al (2002) Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J Clin Oncol 20:3404-3412
5. Xenidis N, Vlachonikolis I, Mavroudis D, Perraki M, Stathopoulou A, Lianidou E et al (2003) Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer. Ann Oncol 14:849-855 (Pubitemid 36827199)
6. Xenidis N, Perraki M, Kafousi M, Apostolaki S, Lianidou ES, Georgoulias V et al (2006) Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. J Clin Oncol 24:3756-3762 (Pubitemid 46622314)
7. Ignatiadis M, Kallergi G, Ntoulia M, Lianidou E, Georgoulias V, Mavroudis D et al (2008) Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer. Clin Cancer Res 14:2593-2600
8. Ignatiadis M, Xenidis N, Perraki M, Lianidou E, Sotiriou C, Georgoulias V et al (2007) Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer. J Clin Oncol 25:5194-5202 (Pubitemid 350232250)
9. Xenidis N, Ignatiadis M, Apostolaki S, Perraki M, Georgoulias V, Mavroudis D et al (2009) Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. J Clin Oncol 27:2177-2184
10. Cristofanilli M, Budd GT, Ellis MJ, Allard WJ, Terstappen LW, Hayes DF et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351:781-791 (Pubitemid 39095313)
11. Lianidou ES, Markou A (2011) Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Clin Chem 57(9):1242-1255 [Epub 22 Jul 2011]
12. Lianidou ES, Markou A (2011) Review: circulating tumor cells as emerging tumor biomarkers in breast cancer. Clin Chem Lab Med. 2011 Jul 29 [Epub ahead of print]
13. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611-622
14. Slade MJ, Smith BM, Sinnett HD, Cross NC, Coombes RC (1999) Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol 17:870-879 (Pubitemid 29109317)
15. Stathopoulou A, Gizi A, Perraki M, Apostolaki S, Malamos N, Mavroudis D et al (2003) Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system. Clin Cancer Res 9:5145-5151 (Pubitemid 37413564)
16. Stathopoulou A, Ntoulia M, Perraki M, Apostolaki S, Mavroudis D, Malamos N, Georgoulias V, Lianidou ES (2006) A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer. Int J Cancer 119:1654-1659 (Pubitemid 44258772)
17. Ntoulia M, Stathopoulou A, Ignatiadis M, Malamos N, Mavroudis D, Georgoulias V et al (2006) Detection of mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR. Clin Biochem 39:879-887 (Pubitemid 44363084)
18. Payne RE, Yagüe E, Slade MJ, Apostolopoulos C, Jiao LR, Ward B, Coombes RC et al (2009) Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients. Pharmacogenomics 10:51-57
19. Liu Z, Fusi A, Schmittel A, Tinhofer I, Schneider A, Keilholz U (2010) Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine. Cancer Biol Ther 10:860-864
20. Lankiewicz S, Rother E, Zimmermann S, Hollmann C, Korangy F, Greten TF (2008) Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells. Cell Oncol 30(6):463-471
21. Ring AE, Zabaglo L, Ormerod MG, Smith IE, Dowsett M (2005) Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques. Br J Cancer 92:906-912 (Pubitemid 40462638)
22. Fehm T, Braun S, Muller V, Janni W, Naume B, Pantel K et al (2006) A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer 107:885-892 (Pubitemid 44291136)
23. Obermayr E, Sanchez-Cabo F, Tea MK, Singer CF, Krainer M, Fischer MB et al (2010) Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients. BMC Cancer 10:666
24. Reinholz MM, Nibbe A, Jonart LM, Houghton R, Zehentner B, Roche PC et al (2005) Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer. Clin Cancer Res 11:3722-3732 (Pubitemid 40685589)
25. Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S (2009) Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res 11:R46
26. Fehm T, Hoffmann O, Aktas B, Becker S, Solomayer EF, Wallwiener D et al (2009) Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Breast Cancer Res 11:R59
27. Sieuwerts AM, Kraan J, Bolt-de Vries J, van der Spoel P, Mostert B, Martens JW et al (2009) Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR. Breast Cancer Res Treat 118:455-468
28. Strati A, Markou A, Parisi C, Politaki E, Mavroudis D, Georgoulias V, Lianidou ES (2011) Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR. BMC Cancer 11:422
29. Markou A, Strati A, Malamos N, Georgoulias V, Lianidou ES (2011) Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay. Clin Chem 57(3):421-430
30. Mego M, Mani SA, Cristofanilli M (2010) Molecular mechanisms of metastasis in breast cancer-clinical applications. Nat Rev Clin Oncol 7:693-701
31. Balic M, Rapp N, Stanzer S, Lin H, Strutz J, Szkandera J et al (2011) Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells. Appl Immunohistochem Mol Morphol 19:33-40
32. Kallergi G, Markomanolaki H, Giannoukaraki V, Papadaki MA, Strati A, Lianidou ES et al (2009) Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients. Breast Cancer Res 11:R84
33. Ignatiadis M, Rothé F, Chaboteaux C, Durbecq V, Rouas G, Criscitiello C et al (2011) HER2- positive circulating tumor cells in breast cancer. PLoS One 6:e15624
34. Fehm T, Müller V, Aktas B, Janni W, Schneeweiss A, Stickeler E et al (2010) HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial. Breast Cancer Res Treat 124:403-412
35. Tewes M, Aktas B, Welt A, Mueller S, Hauch S, Kimmig R et al (2009) Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies. Breast Cancer Res Treat 115:581-590
36. Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, Uhr J et al (2004) HER-2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci U S A 101:9393-9398 (Pubitemid 38812885)
37. Bozionellou V, Mavroudis D, Perraki M, Stathopoulou A, Lianidou E, Georgoulias V et al (2004) Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin- 19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer. Clin Cancer Res 10:8185-8194 (Pubitemid 40053377)
38. Riethdorf S, Müller V, Zhang L, Rau T, Loibl S, Komor M et al (2010) Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial. Clin Cancer Res 16(9):2634-2645
39. Cao S, Li Y, Li J, Li CF, Zhang W, Yang ZQ et al (2010) Quantitative determination of HER2 expression by confocal microscopy assay in CTCs of breast cancer. Oncol Rep 23:423-428
40. Apostolaki S, Perraki M, Pallis A, Bozionelou V, Agelaki S, Kanellou P et al (2007) Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance. Ann Oncol 18:851-858 (Pubitemid 47054081)
41. Flores LM, Kindelberger DW, Ligon AH, Capelletti M, Fiorentino M, Loda M et al (2010) Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer. Br J Cancer 102:1495-1502
42. Munzone E, Nolé F, Goldhirsch A, Botteri E, Esposito A, Zorzino L et al (2010) Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer. Clin Breast Cancer 10:392-397
43. Bonnomet A, Brysse A, Tachsidis A, Waltham M, Thompson EW, Polette M et al (2010) Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia 15:261-273
44. Chimonidou M, Strati A, Tzitzira A, Sotiropoulou G, Malamos N, Georgoulias V, Lianidou ES (2011) DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. Clin Chem 57(8):1169-1177
45. Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, Inserra E, Diederichs S, Iafrate AJ, Bell DW, Digumarthy S, Muzikansky A, Irimia D, Settleman J, Tompkins RG, Lynch TJ, Toner M, Haber DA (2008) Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359(4):366-377 [Epub 2 Jul 2008]
46. Kitago M, Koyanagi K, Nakamura T, Goto Y, Faries M, O'Day SJ, Morton DL, Ferrone S, Hoon DS (2009) mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigenspecific monoclonal antibody beads. Clin Chem 55(4):757-764 [Epub 20 Feb 2009]
47. Jiang Y, Palma JF, Agus DB, Wang Y, Gross ME (2010) Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer. Clin Chem 56(9):1492-1495 [Epub 25 Jun 2010]
48. Punnoose EA, Atwal SK, Spoerke JM, Savage H, Pandita A, Yeh RF et al (2010) Molecular biomarker analyses using circulating tumor cells. PLoS One 5:e12517
49. Sieuwerts AM, Mostert B, Bolt-de Vries J, Peeters D, de Jongh FE, Stouthard JM, Dirix LY, van Dam PA, Van Galen A, de Weerd V, Kraan J, van der Spoel P, Ramírez-Moreno R, van Deurzen CH, Smid M, Yu JX, Jiang J, Wang Y, Gratama JW, Sleijfer S, Foekens JA, Martens JW (2011) mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clin Cancer Res 17(11):3600-3618 [Epub 19 Apr 2011]
50. Becker S, Becker-Pergola G, Banys M, Krawczyk N, Wallwiener D, Solomayer E et al (2009) Evaluation of a RT-PCR based routine screening tool for the detection of disseminated epithelial cells in the bone marrow of breast cancer patients. Breast Cancer Res Treat 117:227-233
51. Van der Auwera I, Peeters D, Benoy IH, Elst HJ, Van Laere SJ, Prové A et al (2010) Circulating tumour cell detection: a direct comparison between the Cell Search System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br J Cancer 102:276-284
52. Tibbe AG, Miller MC, Terstappen LW (2007) Statistical considerations for enumeration of circulating tumor cells. Cytometry A 71:154-162 (Pubitemid 46355340)